Back to News
Market Impact: 0.35
Amgen Inc. Reports Third Quarter 2026 Total Revenues of $10.4 billion
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Amgen reported third-quarter 2026 revenue of $10.4 billion, up 8% year over year. GAAP EPS rose 19% to $7.08 from $5.93, with the company attributing the increase to higher revenue; the provided article text is truncated before further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
AMGN0.65
More News
- UBS raises Amgen stock price target to $530 on diversification
- Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story
- Truist raises Amgen stock price target on earnings beat
- Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales